Avian paramyxovirus (APMV-1) in pigeons

Alert

Avian paramyxovirus (APMV-1) in pigeons is restricted matter.

Under Queensland legislation, if you suspect clinical avian paramyxovirus in any pigeon (domestic or feral), you must report it to:

Cause

APMV-1 in pigeons is caused by pigeon-adapted strains of avian paramyxovirus type 1.

The virus multiplies mainly in the respiratory and digestive tracts and is shed in respiratory secretions and faeces.

Other names

  • Avian paramyxovirus type 1 in pigeons
  • Pigeon paramyxovirus type 1 (PPMV-1)
  • APMV-1 in pigeons

Description

APMV-1 is a viral disease that primarily affects pigeons. It spreads rapidly in lofts and often causes high rates of illness and death.

APMV-1 is not bird flu (Avian influenza).

Distribution

Worldwide

Pigeon-adapted strains of APMV-1 are found in many countries.

The virus is widespread in domestic and wild pigeons in many regions and can cause major losses in racing and exhibition birds.

Australia

APMV-1 in pigeons was first detected in Australia in 2011. Since then, it has been confirmed in racing, fancy and feral pigeons in Victoria and New South Wales.

APMV-1 is considered to be established and widely-distributed in Australia.

Queensland

In Queensland, the spread of APMV-1 in pigeons has occurred when:

  • infected pigeons or eggs are moved from affected states
  • baskets, cages or other equipment contaminated with the virus are moved without cleaning
  • biosecurity is poor at lofts, shows and races
  • feral pigeons fly from other affected states.

Hosts

  • Pigeons
  • Other birds exposed to infected pigeons or contaminated environments

Life cycle

In animals:

  • Pigeons become infected mainly by contact with diseased or carrier pigeons.
  • Infected birds shed virus in faeces and respiratory secretions.
  • The virus multiplies in the respiratory and digestive systems, causing gastrointestinal and neurological signs.
  • Sick birds can die within a few days of becoming ill.
  • Some birds may recover but continue to shed the virus for a time.

In the environment:

  • Faeces and secretions contaminate feed, water, loft floors, perches and equipment.
  • Virus survives for several weeks in cool, damp conditions, particularly in organic material.
  • It survives for shorter periods in hot, dry conditions and sunlight.
  • Birds become infected through contact with contaminated faeces, surfaces, equipment, feed, water and clothing.

Affected animals

  • Pigeons
  • Backyard poultry
  • Aviary birds
  • Other birds exposed to infected pigeons or contaminated environments

Clinical signs

  • Sudden death (within 3 days of illness)
  • Lethargy and reluctance to fly
  • Vomiting or regurgitation
  • Diarrhoea
  • Weight loss and poor body condition
  • Neurological signs (head flicking, circling, twisted necks)
  • Laboured breathing
  • Runny eyes and beak

The pattern and severity of signs can vary between lofts and individual birds.

Differential diagnoses

Laboratory testing is required to confirm APMV-1 in pigeons.

Impacts

If not controlled quickly, APMV-1 in pigeons can cause:

  • high illness and death rates
  • loss of valuable racing and exhibition birds
  • cancellation or disruption of races, shows and sales
  • costs for veterinary investigations, testing and flock management
  • increased risk to backyard and commercial poultry flocks if biosecurity is poor.

The disease can have significant emotional and financial impacts on pigeon owners.

How it is spread

Environmental

APMV-1 in pigeons enters the environment in faeces and respiratory secretions from infected pigeons.

The virus can:

  • contaminate loft floors, perches and nesting boxes
  • contaminate baskets, crates, show pens and transport vehicles
  • contaminate feed and water sources
  • survive for several weeks in cool, damp, organic material.

Poor cleaning and disinfection increase the risk of virus persistence and spread within and between lofts.

Birds

APMV-1 in pigeons is usually spread by:

  • movement of infected pigeons between lofts, races, shows and sales
  • direct contact between diseased or carrier pigeons and healthy birds
  • mixing flocks at races, shows and shared training or basketing facilities.

Birds become infected through:

  • contact with contaminated faeces and respiratory discharges
  • eating or drinking contaminated feed and water
  • contact with contaminated baskets, cages, equipment and vehicles
  • contact with contaminated clothing and footwear.

Humans

APMV-1 is zoonotic, meaning it can infect humans. Human infection is extremely rare.

People are exposed mainly by:

  • handling sick or dead pigeons
  • contact with contaminated faeces, litter or equipment.

Infection usually causes only mild, short-term conjunctivitis. Anyone who develops eye symptoms or flu-like illness after exposure should seek medical advice.

Risk period

There is risk of infection throughout the year.

Outbreaks are more likely when:

  • birds move frequently between lofts, events and regions
  • new birds are introduced without quarantine or health checks
  • baskets, cages and fittings are shared without effective cleaning
  • lofts are crowded, and hygiene is poor
  • pigeons have contact with feral pigeons, backyard poultry or wild birds.

APMV-1 can survive for weeks in faeces and other material. Contaminated environments remain risky even after sick birds are removed.

Monitoring and action

If you suspect APMV-1 in pigeons:

  • Do not wait for more birds to become sick or die.
  • Isolate sick pigeons from the rest of the loft.
  • Stop the movement of birds, eggs, and equipment on and off the property.
  • Avoid sharing baskets, cages or equipment with other pigeon keepers.
  • Contact your veterinarian to arrange examination and testing.

Legal obligations

If you become aware of or suspect clinical APMV-1 in any bird, you must report this as soon as practicable to:

If you own, treat or manage birds, you have a general biosecurity obligation to take all reasonable and practical measures to prevent or minimise the effects of biosecurity risks such as APMV-1. This means you are legally required to reduce the risk of APMV-1 and limit its spread when dealing with possible carriers.

Advice for producers

Monitor your pigeons and other birds for:

  • changes in behaviour or flight performance
  • vomiting, diarrhoea or weight loss
  • neurological signs such as head flicking, circling or twisted necks
  • clusters of sick or dead birds in the same loft, aviary or group.

Consider APMV-1 as a possible cause if your flock:

  • has recently attended races, shows or sales
  • has received new birds from other lofts, regions or states
  • shares baskets, cages or equipment with other pigeon keepers
  • has contact with feral pigeons or backyard poultry.

Control

Prevention

Following good biosecurity and management practices will help to prevent disease and restrict its spread.

Guidelines for prevention:

  • Limit the movements of pigeons between lofts and events where possible.
  • Buy birds from reputable lofts with low disease risk and known health status.
  • Quarantine new birds in a separate area for at least 14 days and monitor them daily before introduction.
  • Do not share baskets, cages or equipment unless they are thoroughly cleaned and disinfected between uses.
  • Regularly clean and disinfect lofts, perches, nesting boxes, baskets and feed and water containers.
  • Prevent feed and water from contamination by faeces and other waste.
  • Reduce contact between your pigeons and feral pigeons, backyard poultry and wild birds.
  • Apply strict entry rules for races, shows and sales to exclude sick birds and flocks with recent disease.
  • Consider the use of the Newcastle disease vaccine (off-label).

Owners of pigeon flocks should maintain strong biosecurity and keep Newcastle disease vaccination and other flock vaccinations up to date.

Outbreaks

If APMV-1 in pigeons is suspected or confirmed:

  • Work with your veterinarian to prevent disease in poultry.
  • Isolate affected lofts or aviaries and stop bird movements on and off the property.
  • Implement strict cleaning and disinfection in and around the loft.
  • Review racing, showing and trading practices to reduce further spread.
  • Cooperate with Biosecurity Queensland and follow all directions.

Treatment

There is no specific treatment for APMV-1 in pigeons.

Management focuses on:

  • good husbandry and supportive care for affected birds
  • controlling secondary infections, where advised by a veterinarian
  • strong biosecurity to protect unaffected birds and other flocks.

Some birds may recover but can shed the virus temporarily. Your veterinarian can advise on managing recovered birds and flock-level decisions.

Vaccination

No vaccine is registered in Australia for APMV-1 in pigeons.

Newcastle disease killed (inactivated) vaccines registered for use in poultry may sometimes be used in pigeons to help reduce illness and deaths if infection occurs. This use is off-label and must only be carried out under the written direction of a veterinarian.

Pigeon owners should discuss vaccination options with their veterinarian and follow any vaccination program recommended for their loft.

For detailed vaccination information, see APMV information for veterinarians.

Quarantine

If APMV-1 is confirmed or strongly suspected:

  • Biosecurity Queensland may apply movement restrictions to affected and at-risk lofts.
  • Movements of pigeons, eggs and fittings on and off affected properties may be restricted or controlled.
  • Show, race, and sale organisers may need to implement additional controls or cancel events.

Restrictions are usually lifted after:

  • infected flocks are managed in accordance with veterinary and regulatory advice.
  • cleaning and disinfection are completed.
  • any required monitoring or follow-up testing is finished.

Further information